Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial

European Neuropsychopharmacology

Volumn 24, Issue 8, 2014, Pages 1289-1297

  Sarchielli, Paola ^a   Messina, Paolo ^b   Cupini, Letizia M ^c   Tedeschi, Gioacchino ^d   Di Piero, Vittorio ^e   Livrea, Paolo ^f   Pini, Luigi A ^g   Bernardi, Giorgio ^h   Bono, Giorgio ⁱ   Sandrini, Giorgio ^j   Caproni, Stefano ^a   Corbelli, Ilenia ^a   Pisani, Francesco ^k   Beghi, Ettore ^b   Calabresi, Paolo ^a,l   Pupillo, Elisabetta ^b   Iani, Cesare ^c   Prudenzano, Maria Pia ^f   Diomedi, Marina ^h   Russo, Antonio ^d   Veneziano, Giuseppe ⁱ   Pisani, Laura Rosa ^k   Misaggi, Giulia ⁱ   Clemente, Laura Di ^e   Puledda, Francesca ^e   Guerzoni, Simona ^d   Allena, Marta ^j   more..

^a UNIVERSITY OF PERUGIA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f POLICLINICO   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

ⁱ UNIVERSITY OF INSUBRIA   (Italy)

^j UNIVERSITY OF PAVIA   (Italy)

^k UNIVERSITY OF MESSINA   (Italy)

^l IRCCS FONDAZIONE SANTA LUCIA   (Italy)

more..

Author keywords

Migraine prophylaxis; MOH; Sodium valproate

Indexed keywords

PLACEBO; VALPROIC ACID; TRANQUILIZER;

ADULT; ARTICLE; ASTHENIA; BACKACHE; CONTROLLED STUDY; CYSTITIS; DEPRESSION; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HAIR LOSS; HEARTBURN; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; MULTICENTER STUDY; NAUSEA AND VOMITING; NECK PAIN; PRESYNCOPE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; ADOLESCENT; AGE; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPLICATION; DISABILITY; DRUG OVERDOSE; HEADACHE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; DRUG OVERDOSE; FEMALE; FOLLOW-UP STUDIES; HEADACHE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; VALPROIC ACID; YOUNG ADULT;

EID: 84903375847     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.03.010     Document Type: Article

References (38)

1. Amorim P., Lecrubier Y., Weiller E., Hergueta T., Sheehan D. DSM-IH-R psychotic disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur. Psychiatry 1998, 13:26-34.
2. Atasoy H.T., Atasoy N., Unal A.E., Emre U., Sumer M. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur. J. Pain 2005, 9:285-291.
3. Atkinson M.J., Kumar R., Cappelleri J.C., Hass S.L. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005, 8(Suppl. 1):S9-S24.
4. Autret A., Valade D., Debiais S. Placebo and other psychological interactions in headache treatment. J. Headache Pain 2012, 13:191-198.
5. Bagley C.L., Rendas-Baum R., Maglinte G.A., Yang M., Varon S.F., Lee J., Kosinski M. Validating migraine-specific quality of life questionnaire v2.1 in episodic and chronic migraine. Headache 2012, 52:409-421.
6. Blumenfeld A.M., Schim J.D., Chippendale T.J. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache 2008, 48:210-220.
7. Bowden C.L., Singh V. Valproate in bipolar disorder: 2000 onwards. Acta Psychiatr. Scand. 2005, (Suppl. 426):S13-S20.
8. Calabresi P., Cupini L.M. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol. Sci. 2005, 26:62-68.
9. Corbelli I., Caproni S., Eusebi P., Sarchielli P. Drug-dependence behaviour and outcome of medication-overuse headache after treatment. J. Headache Pain 2012, 13:653-660.
10. D'Souza A., Onem E., Patel P., La Gamma E.F., Nankova B.B. Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res. 2009, 1247:1-10.
11. Evers S., Jensen R., European Federation of Neurological Societies Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur. J. Neurol. 2011, 18:1115-1121.
12. Freitag F.G., Diamond S., Diamond M.L., Urban G.J. Divalproex in the long-term treatment of chronic daily headache. Headache 2001, 41:271-278.
13. Galli F., Pozzi G., Frustaci A., Allena M., Anastasi S., Chirumbolo A., Ghiotto N., Guidetti V., Matarrese A., Nappi G., Pazzi S., Quartesan R., Sances G., Tassorelli C. Differences in the personality profile of medication-overuse headache sufferers and drug addict patients: a comparative study using MMPI-2. Headache 2011, 51:1212-1227.
14. Grazzi L., Andrasik F., D'Amico D., Usai S., Kass S., Bussone G. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Headache 2004, 44:678-683.
15. Hagen K., Albretsen C., Vilming S.T., Salvesen R., Grønning M., Helde G., Gravdahl G., Zwart J.A., Stovner L.J. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J. Headache Pain 2011, 12:315-322.
16. Hagen K., Jensen R., Bøe M.G., Stovner L.J. Medication overuse headache: a critical review of end points in recent follow-up studies. J. Headache Pain 2010, 11:373-377.
17. Kavuk I., Katsarava Z., Selekler M., Sayar K., Agelink M.W., Limmroth V., Diener H.C. Clinical features and therapy of medication overuse headache. Eur. J. Med. Res. 2004, 9:565-569.
18. Kim S.W., Dysken M.W., Kuskowski M. The Yale-Brown obsessive-compulsive scale: a reliability and validity study. Psychiatry Res. 1990, 34:99-106.
19. Linde M., Mulleners W.M., Chronicle E.P., McCrory D.C. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst. Rev. 2013, 6:CD010611.
20. Munksgaard S.B., Allena M., Tassorelli C., Rossi P., Katsarava Z., Bendtsen L., Nappi G., Jensen R., Comoestas Consortium What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information?. J. Headache Pain 2011, 12:91-96.
21. Olesen J. Detoxification for medication overuse headache is the primary task. Cephalalgia 2012, 32:420-422.
22. Osman A., Kopper B.A., Barrios F.X., Osman J.R., Wade T. The Beck anxiety inventory: reexamination of factor structure and psychometric properties. J. Clin. Psychol. 1997, 53:7-14.
23. Paemeleire K., Crevits L., Goadsby P.J., Kaube H. Practical management of medication-overuse headache. Acta Neurol. Belg. 2006, 106:43-51.
24. Radat F., Creac'h C., Swendsen J.D., Lafittau M., Irachabal S., Dousset V., Henry P. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005, 25:519-522.
25. Raistrick D., Bradshaw J., Tober G., Weiner J., Allison J., Healey C. Development of the Leeds dependence questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction 1994, 89:563-572.
26. Richter P., Werner J., Heerlein A., Kraus A., Sauer H. On the validity of the Beck depression inventory: a review. Psychopathology 1998, 31:160-168.
27. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cell Mol. Life Sci. 2007, 64:2090-2103.
28. Rossi P., Faroni J.V., Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia 2008, 28:1196-1200.
29. Rossi P., Faroni J.V., Tassorelli C., Nappi G. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J. Headache Pain 2013, 14:10.
30. Rothrock J.F., Mendizabal J.E. An analysis of the "carry-over effect" following successful short-term treatment of transformed migraine with divalproex sodium. Headache 2000, 40:17-19.
31. Sances G., Galli F., Anastasi S., Ghiotto N., De Giorgio G., Guidetti V., Firenze C., Pazzi S., Quartesan R., Gallucci M., Nappi G. Medication-overuse headache and personality: a controlled study by means of the MMPI-2. Headache 2010, 50:198-209.
32. Silberstein S., Tfelt-Hansen P., Dodick D.W., Limmroth V., Lipton R.B., Pascual J., Wang S.J., Task Force of the International Headache Society Clinical Trials Subcommittee Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008, 28:484-495.
33. Stewart W.F., Lipton R.B., Kolodner K.B., Sawyer J., Lee C., Liberman J.N. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000, 88:41-52.
34. Terbach N., Williams R.S. Structure-function studies for the panacea, valproic acid. Biochem. Soc. Trans. 2009, 37:1126-1132.
35. Xu X., Müller-Taubenberger A., Adley K.E., Pawolleck N., Lee V.W., Wiedemann C., Sihra T.S., Maniak M., Jin T., Williams R.S. Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid. Eukaryot. Cell 2007, 6:899-906.
36. Yurekli V.A., Akhan G., Kutluhan S., Uzar E., Koyuncuoglu H.R., Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J. Headache Pain 2008, 9:37-41.
37. Zed P.J., Loewen P.S., Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann. Pharmacother. 1999, 33:61-72.
38. Zeeberg P., Olesen J., Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006, 26:1192-1198.